Drug Profile
AZD 5672
Alternative Names: AZD5672Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Antirheumatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 31 Jul 2009 Discontinued - Phase-II for Rheumatoid arthritis in USA (unspecified route)
- 31 Jul 2007 Phase-II clinical trials in Rheumatoid arthritis in USA (unspecified route)
- 08 Jun 2006 Phase-I clinical trials in Rheumatoid arthritis (unspecified route)